Press Releases

Bausch + Lomb Acquires Doctor’s Allergy Formula Diagnostic System

Published

9 years ago

October 20, 2015

(Press Release) Bausch + Lomb has entered into a definitive agreement to acquire Doctor’s Allergy Formula, LLC, which will be integrated under the company’s pharmaceuticals division.

The FDA-approved in-office Doctor’s Allergy Formula test enables eye care practitioners to objectively diagnose and identify the root cause of patient’s ocular allergies. The three-minute ocular allergy diagnostic test utilizes a panel of 60 allergens that are specific to each region of the country and provides results within 15 minutes.

“The addition of the Doctor’s Allergy Formula to Bausch + Lomb’s Pharmaceuticals business will further enhance our diagnostic portfolio of products for eye care practitioners in the rapidly evolving segment of ocular surface disease,” Tracy Valorie, senior vice president and general manager, Bausch + Lomb Pharmaceuticals.

“We are committed to delivering meaningful products to serve the needs of the eye care community and their patients and Doctor’s Allergy Formula is just one example. We congratulate the Doctor’s Allergy Formula team for identifying and successfully addressing this important area of unmet need and look forward to working with them to bring the benefits of this innovative diagnostic test to even more of our customers.”

The knowledge obtained from the Doctor’s Allergy Formula test results can help physicians identify the offending allergens and aid physicians in developing a customized treatment protocol. The Doctor’s Allergy Formula test, which is typically covered by major medical insurances, helps to distinguish ocular surface disease pathology such as dry eyes, ocular allergies and blepharitis as routinely these signs and symptoms of OSD can be similar.

“Doctor’s Allergy Formula launched a little more than two years ago and has grown to be a leader in the diagnostic allergy market,” said Howard Loff, M.D., chief medical officer and founder of Doctor’s Allergy Formula, LLC. “With many leading eye doctors utilizing the diagnostic system today, we are excited to be joining Bausch + Lomb to bring the benefits of this innovative test to even more ophthalmologists, which I believe will soon become the standard-of-care.”

For more information on Doctor’s Allergy Formula, visit drsallergyformula.com.

The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width³ according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion⁴ and seamless transitions from near to far.

For more information, visit here.